Acute myeloid leukemia (AML): What it is, how it’s treated and what’s on the horizon

Dr. David Sanford hematologist at the Leukemia and Bone Marrow Transplant Program at the Vancouver General Hospital, will discuss what AML is, how it develops, how it is treated, and some of the most promising new treatments for the disease.  

Virtual Event

Virtual Event


14:00 - 14:50
AML: What it is, how it’s treated and what’s on the horizon
14:50 - 15:00


Dr. David Sanford
Dr. David Sanford
Clinical Assistant Professor, Vancouver General Hospital
Dr. David Sanford joined the Leukemia/BMT Program of British Columbia in September 2015. He previously completed training in Hematology at the University of Western Ontario. Following this, he undertook a Leukemia Fellowship at MD Anderson Cancer Center in Houston, Texas. He has interests in clinical research in acute myeloid leukemia, including the development of molecularly targeted therapies as well as the role of minimal residual disease in guiding treatment.